KE
KEQU.US Kewaunee Scientific Corporation
- Market cap
- USD 103M
- P/E
- 12.9x
- P/B
- 1.38x
- ROE
- 9.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.
Is KEQU.US undervalued?
Graham numberKEQU.US trades 11.0% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Kewaunee Scientific Corporation fundamental analysis
No fundamental analysis for Kewaunee Scientific Corporation yet.
Kewaunee Scientific Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Kewaunee Scientific Corporation
Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. It operates through two segments, Lab Products Group (LPG) and International. The company offers steel and wood casework and laboratory cabinetry, fume hoods, adaptable modular and flexible systems, movable workstations, stand-alone and work benches, computer …
Full company profileKewaunee Scientific Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Kewaunee Scientific Corporation annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 139M | 158M | 147M | 148M | 147M | 169M | 219M | 204M | 240M | 282M | 265M |
| Gross Profit | 26.6M | 32.0M | 25.3M | 23.4M | 24.0M | 24.2M | 35.6M | 52.1M | 68.9M | 80.4M | 78.6M |
| Operating Income | 6.54M | 9.09M | 2.11M | -2.35M | -1.32M | -2.61M | 3.63M | 18.3M | 17.8M | 16.7M | 12.6M |
| EBITDA | 9.24M | 12.0M | 4.68M | 281K | 459K | 916K | 8.16M | 18.0M | 22.8M | 23.9M | 19.0M |
| Net Income | 4.52M | 5.19M | 1.53M | -4.62M | -3.61M | -6.00M | 1.36M | 18.8M | 11.4M | 9.62M | 6.82M |
| EPS | 1.66 | 1.87 | 0.55 | -1.68 | -1.31 | -2.15 | 0.47 | 6.38 | 3.83 | 3.22 | 2.34 |
| Balance Sheet | |||||||||||
| Total Assets | 80.4M | 84.4M | 87.2M | 83.9M | 89.4M | 119M | 119M | 135M | 195M | 178M | 176M |
| Total Liabilities | 36.3M | 36.8M | 39.5M | 45.2M | 47.9M | 82.6M | 80.4M | 78.6M | 128M | 101M | 98.6M |
| Shareholders' Equity | 44.1M | 47.5M | 47.7M | 38.4M | 41.2M | 35.7M | 37.4M | 54.8M | 64.5M | 74.7M | 75.0M |
| Cash & Short-term Investments | 12.5M | 9.72M | 10.6M | 4.37M | 5.21M | 4.43M | 8.08M | 23.3M | 14.9M | 11.6M | 8.25M |
| Total Debt | 6.94M | 6.32M | 10.9M | 13.8M | 16.1M | 67.6M | 12.9M | 11.0M | 50.2M | 30.2M | 55.5M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 11.7M | 3.18M | 2.49M | 4.16M | 912K | -7.89M | -3.79M | 19.6M | 14.8M | 18.6M | 7.90M |
| Capital Expenditure | 2.61M | 3.40M | 4.21M | 2.47M | 2.40M | 1.91M | 4.15M | 4.37M | 2.17M | 3.94M | 3.09M |
| Free Cash Flow | 9.05M | -212K | -1.72M | 1.70M | -1.49M | -9.79M | -7.94M | 15.2M | 12.6M | 14.7M | 4.82M |
| Ratios | |||||||||||
| ROE | 10.2% | 10.9% | 3.2% | -12.0% | -8.7% | -16.8% | 3.6% | 34.2% | 17.7% | 12.9% | 9.1% |
| ROA | 5.6% | 6.1% | 1.8% | -5.5% | -4.0% | -5.1% | 1.1% | 13.9% | 5.9% | 5.4% | 3.9% |
| Net Profit Margin | 3.3% | 3.3% | 1.0% | -3.1% | -2.4% | -3.6% | 0.6% | 9.2% | 4.7% | 3.4% | 2.6% |
| Debt to Equity | 0.16x | 0.13x | 0.23x | 0.36x | 0.39x | 1.89x | 0.35x | 0.20x | 0.78x | 0.40x | 0.74x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Kewaunee Scientific Corporation dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Sep 9, 2019
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | USD 108K | 0.04 | - |
| 2020 | USD 1.04M | 0.38 | - |
| 2019 | USD 2.03M | 0.73 | 132.8% |
| 2018 | USD 1.79M | 0.65 | 34.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 3:2 on Jan 7, 1985.
Who owns Kewaunee Scientific Corporation
- Insiders 24.42%
- Institutions 41.56%
- Public & others 34.02%
- Shares outstanding 2.90M
- Free float 2.16M
Top funds holding KEQU.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 82.8K | 2.86% | 0.00% | Sep 2026 |
| DFA U.S. Small Cap Value I | 51.1K | 1.76% | +18.48% | Sep 2026 |
| VT De Lisle America B USD | 50.6K | 1.75% | 0.00% | Oct 2026 |
| Royce Small-Cap Special Equity Invmt | 49.7K | 1.72% | 0.00% | Sep 2026 |
| Avantis US Small Cap Value ETF | 38.8K | 1.34% | 0.00% | Oct 2026 |
| DFA US Micro Cap I | 21.4K | 0.74% | 0.00% | Sep 2026 |
| DFA U.S. Targeted Value I | 20.9K | 0.72% | 0.00% | Sep 2026 |
| Dimensional US Targeted Value ETF | 16.9K | 0.58% | 0.00% | Oct 2026 |
| DFA U.S. Small Cap I | 13.1K | 0.45% | 0.00% | Sep 2026 |
| Dimensional US Small Cap ETF | 9.32K | 0.32% | 0.00% | Oct 2026 |
| Fidelity Extended Market Index | 9.11K | 0.31% | -16.83% | Sep 2026 |
| Dimensional US Small Cap Value ETF | 7.96K | 0.28% | 0.00% | Sep 2026 |
| iShares Micro-Cap ETF | 6.73K | 0.23% | 0.00% | Oct 2026 |
| DFA U.S. Core Equity 2 Instl | 6.31K | 0.22% | 0.00% | Sep 2026 |
| EA Bridgeway Ultra-Small Company Mkt ETF | 5.66K | 0.20% | 0.00% | Oct 2026 |
| Bridgeway Ultra-Small Company | 5.60K | 0.19% | 0.00% | Jun 2026 |
| DFA U.S. Core Equity 1 I | 4.86K | 0.17% | +9.02% | Sep 2026 |
| Fidelity Total Market Index | 3.82K | 0.13% | 0.00% | Sep 2026 |
| Avantis US Small Cap Equity ETF | 3.76K | 0.13% | 0.00% | Oct 2026 |
| Dimensional US Core Equity 2 ETF | 3.74K | 0.13% | 0.00% | Oct 2026 |
Top institutions holding KEQU.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Northern Trust Corp | 238K | 8.22% | -3.19% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 175K | 6.05% | 0.00% | Sep 2026 |
| Minerva Advisors LLC | 149K | 5.16% | +9.29% | Jun 2026 |
| Vanguard Capital Management, LLC | 110K | 3.80% | -2.19% | Jun 2026 |
| Punch & Associates Inv Mgmt Inc | 106K | 3.65% | +4.81% | Jun 2026 |
| Renaissance Technologies Corp | 90.9K | 3.14% | -4.62% | Sep 2026 |
| Royce & Associates, LP | 49.7K | 1.72% | +3.54% | Jun 2026 |
| American Century Companies Inc | 49.5K | 1.71% | 0.00% | Sep 2026 |
| Geode Capital Management, LLC | 24.9K | 0.86% | +1.85% | Jun 2026 |
| Mink Brook Asset Management LLC | 21.4K | 0.74% | 0.00% | Jun 2026 |
| Northeast Investment Management | 20.0K | 0.69% | 0.00% | Sep 2026 |
| Morgan Stanley - Brokerage Accounts | 16.8K | 0.58% | -15.58% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 13.2K | 0.45% | +0.67% | Jun 2026 |
| Wealth Enhancement Advisory Services, LLC | 12.7K | 0.44% | 0.00% | Jun 2026 |
| BlackRock Inc | 12.0K | 0.41% | +20.70% | Jun 2026 |
| Bridgeway Capital Management, LLC | 11.8K | 0.41% | 0.00% | Jun 2026 |
| State Street Corp | 10.0K | 0.35% | 0.00% | Jun 2026 |
| Verdad Advisers, LP | 10.0K | 0.35% | 0.00% | Jun 2026 |
| LPL Financial Corp | 8.00K | 0.28% | 0.00% | Jun 2026 |
| Arrowstreet Capital Limited Partnership | 6.62K | 0.23% | 0.00% | Jun 2026 |
Kewaunee Scientific Corporation company profile
- Company name
- Kewaunee Scientific Corporation
- Ticker
- KEQU.US
- Exchange
- USA Stocks
- Listed since
- Feb 25, 1992
- Sector
- Consumer Cyclical
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,231
- Fiscal year end
- April
- Address
- 2700 West Front Street, Statesville, NC, United States, 28677-2927
- Phone
- 704 873 7202
- Website
- kewaunee.com
About Kewaunee Scientific Corporation
Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. It operates through two segments, Lab Products Group (LPG) and International. The company offers steel and wood casework and laboratory cabinetry, fume hoods, adaptable modular and flexible systems, movable workstations, stand-alone and work benches, computer enclosures, biological safety cabinets, CO2 incubators, ultralow freezers, epoxy resin work surfaces and sinks, and other laboratory products. It also provides facility design, detailed engineering, construction, and project management services. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and healthcare markets; and its technical products are used in facilities manufacturing computers and light electronics, and by users of computer and networking furniture. It sells its products through dealers, its subsidiaries, and a national stocking distributor. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.
Kewaunee Scientific Corporation management
7- Mr. Thomas David Hull IIIPresident, CEO & Director · born 1976
- Mr. Donald T. Gardner IIIEVP of Finance, CFO, Treasurer & Secretary · born 1979
- Mr. Douglas J. BatdorffSenior VP of Manufacturing Operations & Quality Systems · born 1973
- Mr. Ryan S. NobleSenior VP of Sales & Market Development · born 1978
- Ms. Elizabeth D. PhillipsSenior Vice President of People & Culture · born 1977
- Mr. Mandar M. RanadeSenior VP of Information Technology & Engineering · born 1969
- Mr. Bhoopathy SathyamurthySVP of Kewaunee Scientific Corporation Singapore Pte, & President of Kewaunee International Group · born 1969